AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Transcranial Pulse Stimulation (TPS) in Post-COVID-19

RecruitingNAAges 20 Years - 80 YearsAllMedical University of Vienna
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The objective of the present study is to demonstrate treatment efficacy of transcranial pulse stimulation for patients with Post-COVID-19 related neurological symptoms (fatigue, cognitive deficits, mood deterioration). Fatigue, as measured by the Fatigue Impact Scale (FIS), will represent the primary outcome variable. The verum treatment will be compared to a sham (placebo) condition.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Signed written informed consent * PCR-confirmed SARS-CoV-2 infection, laboratory confirmed antibody detection for SARS-CoV-2, or physician-verified COVID-19 infection * At least 12 months after initial SARS-CoV-2 infection that led to Post-COVID (subsequent SARS-CoV-2 infections are not a reason for exclusion) * Diagnosis of Post-COVID Syndrome or independent suspected diagnosis of Post-COVID Syndrome (Considering that physicians generally hesitate to provide clear-cut Post-COVID diagnoses, a tentative diagnosis by an independent general practitioner or a specialist in a field associated with Post-COVID will suffice for entering this study) * Age: 20-80 * Evidence of a negative pregnancy test if medically adequate Exclusion Criteria: * Clinically relevant realization of pre-COVID diseases with similar symptoms as Post-COVID * MoCA score \<17 (cut-off for dementia) * BDI-II score โ‰ฅ29 (cut-off for severe depression) * FIS \<10 (cut-off for no fatigue) * Brain implants * Non-MR-compatible metal parts in the body * Metal parts in the head * Use of anticoagulants * Non-MR-compatible claustrophobia * Non-MR-compatible pacemaker * Pregnant and breastfeeding women * Clinically relevant history of surgery on the head, heart, or vessels * Relevant corticosteroid treatments administered within 6 weeks prior to the first application * Tumor of the head if relevant for treatment * Blood clotting disorders * Participation in other studies
๐Ÿ’Š

What it tests

  • Transcranial pulse stimulation Verum
  • Transcranial pulse stimulation Sham
๐Ÿ“

Where

1 site
Medical University of Vienna
Vienna, Austria
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy